Dr. Rongxin Zhang 张荣欣
Chief Physician, Lecturer
Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of colorectal cancer, liver metastases from colorectal cancer, and comprehensive care for locally advanced rectal cancer. Performs low-position sphincter-preserving surgery.
Dr. Zhang holds a medical doctorate from Sun Yat-sen University and serves as a master’s supervisor. Dr. Zhang was a visiting scholar at the University of Pennsylvania and Queen Mary Hospital, University of Hong Kong.
Professional roles
- Member, Youth Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Youth Editorial Board Member, Journal of Clinical Oncology (JCO) Chinese Edition
- Standing Committee Member, Colorectal Cancer Youth Committee, Guangdong Anti-Cancer Association
- Member, Tumor Support Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Rongxin). Papers usually list the name as Rongxin Zhang or Zhang R.
Selected publications
65 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Adv Sci (Weinh), 2026 (senior author): Single-Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti-PD-1 Resistance in Colorectal Cancer. PubMed 42295773
- Adv Sci (Weinh), 2026 (senior author): A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK-β. PubMed 41405367
- MedComm (2020), 2025 (first author): Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. PubMed 40703195
- Ann Surg Oncol, 2025 (senior author): Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer. PubMed 39948309
- NPJ Precis Oncol, 2024 (senior author): DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening. PubMed 39511298
- Cell Oncol (Dordr), 2024 (senior author): ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways. PubMed 39141315
- Int J Surg, 2024 (first author): Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trial. PubMed 38652147
- Cell Death Dis, 2022 (senior author): Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy. PubMed 35523764
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion